Home

Alerts and recalls

Research and statistics

Sort by

Public Assessment Report of the reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets

This PAR covers the assessment of the proposal to make Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets available through general retail outlets.
- Document type: Research
- Organisation: Medicines and Healthcare products Regulatory Agency
- Updated: 11 February 2022
- Public Assessment Report of the reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets
  1. Introduction Buscopan IBS Relief can be used in adults and children…
Report of the Commission on Human Medicine’s Expert Working Group on benefit-risk and risk minimisation measures of the yellow fever vaccine

An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.
- Document type: Independent report
- Organisation: Commission on Human Medicines
- Updated: 21 November 2019